logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9725497 B1

PDFFull Text
Date of Patent:
Aug. 08, 2017

Filed:

Nov. 21, 2013

Egfr and c-met fibronectin type iii domain binding molecules

Applicant:

Janssen Biotech, Inc., Horsham, PA (US);

Inventors:

Mark Anderson, Spring House, PA (US);

Ricardo Attar, Spring House, PA (US);

Michael Diem, Spring House, PA (US);

Linus Hyun, Spring House, PA (US);

Steven Jacobs, Spring House, PA (US);

Alastair King, Norristown, PA (US);

Donna Klein, Spring House, PA (US);

Sheri Moores, Spring House, PA (US);

Karyn O'Neil, Spring House, PA (US);

Kristen Picha, Spring House, PA (US);

Assignee:

Janssen Biotech, Inc., Horsham, PA (US);

Attorney:

Eric Dichter

Primary Examiner:

Michael Pak

Int. Cl.
CPC ...
C07K 19/00 (2006.01); C07K 14/78 (2006.01); A61K 45/06 (2006.01); C07K 16/28 (2006.01); C07K 14/705 (2006.01); C07K 14/71 (2006.01); C07K 14/47 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/78 (2013.01); A61K 45/06 (2013.01); C07K 14/47 (2013.01); C07K 14/705 (2013.01); C07K 14/71 (2013.01); C07K 16/28 (2013.01); C07K 16/2863 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2318/20 (2013.01); C07K 2319/70 (2013.01);
Abstract

Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are useful in the generation of therapeutic molecules and treatment and diagnosis of diseases and disorders.

Find Patent Forward Citations

Anderson, Mark. (2017). Egfr and c-met fibronectin type iii domain binding molecules (U.S. Patent No. 9725497). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9725497

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…